Regulators must move quickly on CBD regulation

7 June 2019 - Deborah Wilkes

Premium

The US Food and Drug Administration (FDA) needs to "step up very quickly" with regulation for cannabidiol (CBD) products, says Scott Melville, president and chief executive officer of the US Consumer Healthcare Products Association (CHPA). According to Melville, the current situation in the US is like the "wild west".

Click tags below for more information on topics:

CBD FDA CHPA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: